• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血管扩张剂对慢性心力衰竭患者心律失常特征及发生率的影响]

[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].

作者信息

Bechler-Lisińska J, Cholewa M, Górski L, Markiewicz K

机构信息

Institut für Innere Medizin, Medizinischen Akademie Lódź.

出版信息

Z Gesamte Inn Med. 1990 Mar 1;45(3):71-6.

PMID:2186579
Abstract

In 50 patients with chronic congestive heart failure (CCHF, III or IV class), aged 62.8 +/- 9.1 years, who were treated with digoxin (Dx) and furosemide (F) (investigation A), continuous 24-hour ecg registration was performed according to Holter. Next, this treatment was extended by two-week administration of nifedipine (N) or isosorbide dinitrate (S) (investigation B), followed by one-month addition of captopril (Cp) (investigation C). During the last two weeks Dx, F, N or Dx, F, S were administered with Cp being withdrawn (investigation D). At the end of each stage of the treatment ecg registration was repeated according to Holter. At the same time, during the investigation A there were performed determinations of blood serum sodium, potassium and digoxin concentrations, two-dimensional echocardiography and evaluation of submaximal exercise tolerance. In 96 per cent of patients with CCHF, treated with Dx and F, cardiac rhythm disturbances were found. In 53.3 per cent life-threatening ventricular arrhythmias occurred, including unstable ventricular tachycardia in 11.1 per cent of patients. Addition of N or S to the classical treatment did not decrease either patient number or amounts of cardiac rhythm disturbances in individual classes according to Lown. Also Cp did not affect numbers of patients with cardiac rhythm disturbances, but it decreased numbers of patients with life-threatening ventricular arrhythmias from 53.3 per cent to 28.9 per cent (from 24/45 to 13/45). At the same time, Cp significantly decreased numbers of ventricular arrhythmias in class 3 and 4a (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对50例年龄为62.8±9.1岁的慢性充血性心力衰竭(CCHF,Ⅲ或Ⅳ级)患者采用地高辛(Dx)和呋塞米(F)进行治疗(研究A),并根据动态心电图监测仪进行连续24小时心电图记录。接下来,在经典治疗基础上延长两周给予硝苯地平(N)或硝酸异山梨酯(S)(研究B),随后加用卡托普利(Cp)一个月(研究C)。在最后两周停用Cp,给予Dx、F、N或Dx、F、S(研究D)。在治疗的每个阶段结束时,再次根据动态心电图监测仪进行心电图记录。同时,在研究A期间测定血清钠、钾和地高辛浓度,进行二维超声心动图检查并评估次极量运动耐量。在接受Dx和F治疗的CCHF患者中,96%出现心律失常。53.3%发生危及生命的室性心律失常,其中11.1%的患者出现不稳定室性心动过速。在经典治疗基础上加用N或S并未减少心律失常患者数量或各类心律失常的发生量(根据洛恩分级)。Cp也未影响心律失常患者数量,但将危及生命的室性心律失常患者数量从53.3%降至28.9%(从24/45降至13/45)。同时,Cp显著减少了3级和4a级室性心律失常的数量(p<0.05)。(摘要截断于250字)

相似文献

1
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].[血管扩张剂对慢性心力衰竭患者心律失常特征及发生率的影响]
Z Gesamte Inn Med. 1990 Mar 1;45(3):71-6.
2
[Changes in left-ventricular function in chronic congestive heart failure treated with digoxin, furosemide and vasodilators].[地高辛、呋塞米和血管扩张剂治疗慢性充血性心力衰竭时左心室功能的变化]
Kardiol Pol. 1990 Feb;33(2):107-15.
3
[Effect of treatment with vasodilators on physical exercise tolerance in patients with chronic congestive heart failure].[血管扩张剂治疗对慢性充血性心力衰竭患者体育锻炼耐量的影响]
Pol Tyg Lek. 1993;48(3-4):61-4.
4
[Results of conventional treatment of severe congestive heart failure with vasodilators].[血管扩张剂治疗重度充血性心力衰竭的传统治疗结果]
Wiad Lek. 1992 Jun;45(11-12):403-8.
5
[Effect of using nifedipine by patients with chronic congestive heart failure treated with digoxin and furosemide].[硝苯地平对接受地高辛和呋塞米治疗的慢性充血性心力衰竭患者的影响]
Pol Tyg Lek. 1990;45(23-24):461-5.
6
[Evaluation of the effect of nifedipine in patients with chronic congestive heart failure].[硝苯地平对慢性充血性心力衰竭患者的疗效评估]
Kardiol Pol. 1989;32 Suppl 2:33-40.
7
The antiarrhythmic effect of the ACE inhibitor captopril in patients with congestive heart failure largely is due to its potassium sparing effects.血管紧张素转换酶抑制剂卡托普利对充血性心力衰竭患者的抗心律失常作用主要归因于其保钾作用。
Can J Cardiol. 1992 Jul-Aug;8(6):589-95.
8
[Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].口服西苯唑啉与普罗帕酮预防房性心律失常复发的多中心、随机、双盲研究
Ann Cardiol Angeiol (Paris). 1996 Oct;45(8):469-79.
9
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].[肥厚型心肌病中的心律失常。意义及治疗后果]
Herz. 1985 Apr;10(2):91-101.
10
A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.地尔硫䓬与硝酸异山梨酯对慢性缺血性心力衰竭患者地高辛药效学和药代动力学影响的比较
Saudi Med J. 2002 Jun;23(6):725-31.